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represent an increasing healthcare problem in the years to come with the general aging of the
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(LUTS) and comment upon potential mechanisms which may be responsible for the increasing
prevalence of lower LUTS with increasing age, based on laboratory studies. It is clear that
there is a complex interplay between the various components of the neural innervation struc-
ture of the bladder in leading to changes with age, which are likely to underpin the LUTS which
are seen in the aging bladder.
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Current demographic forecasts have predicted a worldwide
increase in the proportion of the population aged 65e80
years. It is well recognized that the urinary bladder appears
to be particularly susceptible to aging. The prevalence of
both storage and voiding lower urinary tract symptoms
(LUTS) increases significantly over the age of 65 years in
patients of both sexes [1]. It is well recognized thatac.uk (C.R. Chapple).
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tivecommons.org/licenses/by-nc-overactive bladder (OAB) symptom syndrome and urody-
namic evidence of bladder overactivity which is seen in a
proportion of these patients increases in both sexes with
increasing age as does detrusor underactivity and indeed
both can co-exist in the same patient [2]. Furthermore
there is a clearly increasing prevalence of bladder outflow
obstruction in the aging male population. Furthermore
disorders such as diabetes, cerebrovascular accidents and
neurological disease all exert an increasing influence with
increasing age. Understanding how physiological and phar-
macological mechanisms function alters as we(who, please
check the confirmation) age is now vital to ensure the
progress of drug discovery and treatment of diseases in an
aging society.er insights from animal models, Asian Journal of Urology (2017),
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limited risks to life expectancy, they severely impair pa-
tients’ quality of life, in particular OAB, leading to
depression, sleep deprivation, embarrassment and fatigue.
Bladder and continence conditions therefore place a huge
burden on global healthcare resources which is likely to
become even more of an issue as the population continues
to age. While our understanding of the basic physiology of
the bladder is expanding, the underlying pathophysiological
processes are poorly understood, although there is an
increasing emphasis on the importance of both peripheral
afferent mechanisms in the lower urinary tract as well as
altered central transmission and processing of neural in-
formation from the bladder and lower urinary tract.
Normal bladder function is dependent on the integration
of autonomic and somatic mechanisms which coordinate a
complex cycle of filling and emptying. In the first phase of
this cycle, the filling phase, the bladder is relatively
quiescent as filling ensures. The sensory (afferent) nerves
detect changes in bladder volume and distension and
convey information to the central nervous system (CNS).
Sensory information is integrated in the brainstem mictu-
rition centre and when the bladder is full or when it is
convenient to void the second phase, the voiding phase, is
initiated. During voiding motor (efferent) nerves are acti-
vated, resulting in relaxation of the urethral sphincters and
concomitant contraction of the detrusor smooth muscle.
Sensory innervation from the bladder is carried via pel-
vic and hypogastric afferent nerves whose cell bodies lie in
the dorsal root ganglia (DRG). These nerves consist of
myelinated Ad fibers and unmyelinated C fibers which have
polymodal sensitivity responding to a host of mechanical
and chemical stimuli. Deformation of the bladder wall and
therefore mechanical stimulation of the sensory nerve
terminal (mechanosensitivity) results in the formation of an
action potential. This is the basis by which the afferent
nerves detect bladder filling and convey the extent to
which the bladder is full to the brain. Interestingly how-
ever, sensory information from the bladder does not arise
from the afferent nerves alone. It has been suggested that
the epithelial lining of the bladder, the urothelium can
actively participate in sensory transmission [3]. The current
theory is that as the bladder fills, urothelial cells detect the
degree of stretch and release a host of excitatory and
inhibitory chemical mediators. These mediators act on
nearby afferent terminals to modulate and tune the
excitability of the nerves. Therefore, sensory information
from the bladder is a result of both the stimulation of the
nerve terminal and the modulation of the nerves by the
urothelium. This review will detail some of the contempo-
rary developments in this field based on contemporary an-
imal models.
2. In vivo evaluation of age related changes in
bladder function in rodents
The effects of aging on bladder structure and function have
been investigated using both in vivo and in vitro method-
ology in a variety of rodent models. These models include
C57BL6 mice (male and female, 22e25 months old [4e6]),
the senescent-accelerated prone SAMP8 mice (36e38Please cite this article in press as: Birder LA, et al., The aging bladd
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[8e10], female, 24 months old [11]), Fischer/Brown Norway
rats (male, 28e30 months old [12]), Wistar rats (male or
female, 22e37 months old [13e15], Sprague Dawley (SD)
rats (male, 18e24 months old [16,17]). Other species
included dogs [18,19] and guinea pigs [20,21]. Similar to
results from human studies, the rodent models revealed
complex and interdependent changes that varied with
species, strain and sex. In vivo metabolism cage studies
have shown increased voiding frequency in mice and rats,
as well as in rats with chronic bladder ischemia (a risk
factor in aging) [4,7,9,22,23]. Cystometry yielded some-
what more variable results likely due to species and gender
differences and/or anesthesia. For example, voiding fre-
quency increased with age in awake male Fischer/Brown
Norway rats [12], while it decreased in anesthetized female
mice [6]. Several studies reported an increase in bladder
capacity and post-residual voiding volume associated with
decreased voiding efficiency [10,12,24]. Pressure threshold
for voiding increased regardless of species and gender
[10,11,16,24], suggesting disturbances of the afferent sys-
tem. Baseline intravesical pressure also increased [12,16],
suggesting changes in the smooth muscle/bladder wall that
may impact storage function. Spontaneous non-voiding
contractions, considered the hallmark of detrusor over-
activity were also reported [10,12,14,16]. Together, these
studies suggest that in animal models, a mixture of
“detrusor overactivity and underactivity”-like bladder
behavior can be found, and more detailed investigations
are needed. Ischemia, which is a main risk factor in aging,
has shown to result in dynamic changes, resembling in the
initial phase detrusor overactivity (e.g., increased non-
voiding contractions, increased voiding frequency and
decreased voided volume), and progressing with time to
detrusor underactivity (e.g., decreased voiding frequency)
[25]. Thus, depending on the underlying risk factors, aging
may have variable effects on bladder function. Data from
animal models, which seem to be as variable as the data
from human studies in different clinical, may be useful for
understating the progression of bladder function with
aging.
3. In vitro evaluation of age related changes in
micturition reflex components in rodents
Changes observed in overall bladder function are the result
of both structural and functional alterations in each
component of the bladder and its controlling nervous sys-
tem. In vitro studies were employed to elucidate how each
component of the micturition reflex, including the afferent
nerves, spinal cord, brain, efferent nerves, smooth muscle,
urothelium, extracellular matrix and immune system com-
ponents, were affected by aging.
3.1. Afferent systems
The peripheral afferent limb of the micturition includes the
urothelium and afferent nerves. Although the urothelial
functions and urothelial-afferent nerve interactions play an
important role in bladder sensations [26], little is known
about the influence of aging on these components.er insights from animal models, Asian Journal of Urology (2017),
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Fischer/Brown Norway rats) [12], granular appearance of
umbrella cell layer, discoidal vesicles, electron dense
bodies and vacuoles in umbrella layer, often containing
what appears to be cellular debris in all layers [27]. These
could be the result of oxidative stress and altered mito-
chondrial function. In support, increased reactive oxygen
species (ROS) in cultured urothelial cells, associated with
upregulation of transient receptor potential cation channel
subfamily M member 8 (TRPM8) [28], decreased total anti-
oxidant capacity and significantly increased levels of lipid
peroxides, malondialdehyde (MDA) and inducible nitric
oxide synthase (iNOS) (markers of oxidative stress) as well
as ultrastructural alterations in mitochondria with accu-
mulation of lipofuscin [29] have been reported. Changes in
the urothelium can affect afferent neuronal input. It has
been shown that in aged mice the activity of afferent
nerves is augmented during bladder filling (male C57BL6,
3e4 vs. 24 months [4]). This could be due to increased
stretch-induced release of acetylcholine (ACh) from non-
neuronal cells, possibly from the urothelium [30], and/or
increased adenosine 50-triphosphate (ATP) and ACh
bioavailability in the urothelium, as inferred from mea-
surements of transmitter levels in the lumen [4]. If these
findings are similar in humans, they could represent un-
derlying mechanisms for bladder overactivity in the elderly.
Studies in rats indicated that the density of Calcitonin
gene-related peptide (CGRP) fibers was unchanged [31] and
conduction velocity of myelinated and unmyelinated fibers
did not appear to change with age; however, there was a
reduction in the number of small diameter (predominantly
unmyelinated) fibers [15]. These changes, if occurring in
humans, may account for alterations in bladder sensations
in the elderly. Further investigation of urothelial signaling
properties (e.g., receptors, transmitters, intracellular
pathways) and the influence on afferent nerve activity are
still needed.
3.2. Central micturition pathways
The influence of an aging on central micturition pathways is
far less understood. Imaging studies in elderly women with
normal bladder function revealed activation of different
brain areas depending on the bladder fullness. For
example, when the bladder was filled from an empty state,
activity was observed near the periaqueductal gray, an area
important for reflex voiding, and was thought to reflect
unconscious monitoring and relaying of ascending bladder
signals. In contrast, when the bladder was full, further
filling activated cortical areas associated with sensations,
such as regions near the insula, the dorsal anterior cingu-
late cortex and supplementary motor area [32]. Systematic
investigation of CNS centers involved in micturition in ani-
mal models of aging remains to be done.
3.3. Efferent system (sympathetic,
parasympathetic and smooth muscle)
The efferent system includes the sympathetic and para-
sympathetic nerves and the smooth muscle. The sympa-
thetic system is thought to be tonically active during fillingPlease cite this article in press as: Birder LA, et al., The aging bladd
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smooth muscle. The parasympathetic system is active
during voiding and releases ACh to contract the bladder and
nitric oxide (NO) to relax the urethra. Although not sys-
tematically investigated, gross anatomical observations
have shown axonal degeneration in human bladders [33],
and bladder from rats with induced ischemia [25]. Cyst-
ometry studies in rodents have shown increased intra-
vesical pressure [12,16], suggesting changes in the
sympathetic output and/or the smooth muscle/bladder
wall that may impact storage function. Accordingly, histo-
logical studies have found a reduction of the sympathetic
fibers in the aging rat bladder body [31]. On the post-
synaptic site, responses to NE are mediated by b-adrenergic
receptors (b-ARs). In human, b3-AR are the predominant
subtype, while in animals all b-ARs 1e3 subtypes are pre-
sent [34,35]. Studies assessing b-ARs expression yielded
inconsistent results (possible due to species/strain/sex
differences), showing a decrease in b-ARs in aged male
Fischer 344 rats [36], no change in male SD rats and female
Wistar/Rij [14,16], or increase in rabbit [37]. Similarly,
there is some variability in human data, with some studies
showing a decrease in overall b-AR density [38], while more
detailed investigations revealed no changes in b3-AR
expression but small decreases in b2-AR in the urothelium
of the trigone [39]. In vitro smooth muscle strips showed
weaker smooth muscle response (relaxation) to b-AR ago-
nists (noradrenaline, isoproterenol or the b3-AR agonist
BRL37344) in male Wistar rats [13] and human strips [38].
Though changes in b-AR function in the elderly cannot be
excluded, the b3-AR agonist (mirabegron) is efficacious and
well tolerated in these patients [40].
Cystometry studies reported variable changes in mictu-
rition pressure, which is a measure of the efferent para-
sympathetic nerves and smooth muscle contractility [6,16],
suggesting changes in more than one component of the
efferent system. Bladder strips using electric field stimu-
lation (EFS) to activate parasympathetic nerves, which then
release ACh and ATP to contract the smooth muscle, have
shown a general decrease of the EFS-induced contraction,
associated with loss of the atropine resistant component in
some studies [12,16,41]. This correlates with structural
changes that indicated a decrease (w40%) in the number of
acetylcholinesterase (AChE)-positive neurons in the intra-
mural plexus in guinea pigs [42]. These alterations may
impact the strength of the contraction and may lead to
changes in voiding function that could account for the un-
deractive bladder condition. Numerous studies tested the
responsiveness of the smooth muscle to agonists for
muscarinic and purinergic receptors. Again, variability was
present. Muscarinic receptor mediated contraction has
been reported to increase (male Fischer 344 rats [43], male
mice [4]), decrease (male SD rats [16,43,44], male Fisher/
Brown Norway [12] and male mice [5] or remain unchanged
(male Wistar [45] and female Wistar/Rij rats [14]). A sys-
tematic study in rats with induced bladder ischemia (a risk
factor in aging) has shown differential expression pattern
for different subtypes of muscarinic receptors depending
on the time after inducing ischemia. In the early stages of
ischemia (8 weeks), M2 expression was increased and this
was associated with detrusor overactivity (evaluated by
cystometry). In the late stages of ischemia (16 weeks) M2er insights from animal models, Asian Journal of Urology (2017),
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M1 expression increased, and these were associated with
detrusor underactivity (evaluated by cystometry) [25].
Regardless of pharmacological studies in animals, which
seem to be species/strain/sex dependent and many lack
detailed receptor subtype investigation and/or detailed
location of different receptor subtypes (e.g., dome, trig-
one, smooth muscle, urothelium in humans, clinical effec-
tiveness of muscarinic antagonists does not seem to be age
related [46e48]. Patients with OAB discontinue treatment
mainly due to lack of efficacy (i.e., refractory overactive
bladder) and unpleasant side effects. A better under-
standing on the alterations of specific muscarinic receptor
subtypes may help design better antimuscarinic therapies
for the elderly.
The purinergic component of the efferent transmission
has been shown to be upregulated in conditions associated
with overactive bladder [49], including aging [50,51]. It is
believed that increased of ATP release from para-
sympathetic nerves with aging [51] may result in decrease
expression of P2X1 mRNA expression in the smooth muscle
(in human tissue) [52]. In aging rodents, the purinergic
component was also upregulated likely due to increased
purinergic receptor sensitivity [5]. This was associated with
overexpression of P2X3 receptor in the urothelium (male
mice C57BL6 [4]), suggesting differential changes in re-
ceptor expression/function/subtypes the smooth muscle
versus urothelium and perhaps afferent nerves. Further
detailed studies of the purinergic component are needed.
In addition topossible changes in receptor expression and/
or function (muscarinic, b-AR and purinergic), aging impairs
calcium handling in the smooth muscle. Strips from the aged
rats were more susceptible to a calcium channel antagonist
and to reduced extracellular calcium [17,44], aged dissoci-
ated smooth muscle cells showed differences in mobilization
of intracellular calcium [5]) while responses to KCl were
variable [4,5,14,16]. Thus, intracellular pathways involved in
smooth muscle contractility may decline with aging and this
set up the stage for overactive or underactive muscle.
Structural changes in the bladder wall, including wide-
spread degeneration of muscle cells and axons [33,53] and
decrease in the area density of smooth muscle to connec-
tive tissue ratio [53], indicate that fibrosis develops in aged
human bladder. Similarly, in aged rodents fibrosis
(increased collagen deposition) was reported in various
studies [12,16], and was to some extent alleviated by
caloric restriction [41] (obesity is a risk factor for LUTS) or
testosterone supplementation therapy [54] (age dependent
hormonal changes are a risk factor). Recent studies have
found changes in collagenases (matrix metalloproteinase-
13 (MMP-13)) [10] in aging rat bladder.
Collagen and elastin fibers provide structural support as
bladder smooth muscle stretches during bladder filling. Not
only is the amount of these fibers important for proper
bladder function, but also their orientation, conformation
and recruitment during bladder filling. Collagen type III fi-
bers (found in flexible and distensible tissues) display spe-
cific orientations with different bladder volumes, that also
differ according to bladder location [22]. For example,
when empty, fibers appear as loose (wavy) networks with
random orientation. When full, fibers appear long and thin
and lie parallel to urothelium and smooth muscle. ThisPlease cite this article in press as: Birder LA, et al., The aging bladd
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imposing strain on the wall. In aging bladders, changes in
the smooth muscle/collagen ration and possibly extracel-
lular matrix composition [10] likely impair the orientation,
conformation and recruitment of collagen fibers. New
studies (unpublished data, Robertson et al.), using a com-
bination of biaxial stretch and multiphoton imaging, have
shown that fibers in the lamina propria start to flatten (be
recruited to bladder stretch) at lower strains, which may be
equivalent to lower volume, in aging bladders compared to
controls. This suggests that additional tension/stretch may
be imposed on the urothelial cells and/or smooth muscle as
the bladder fills. This can impair the communication be-
tween the urothelium and other cells in the bladder wall
and account for symptoms of the aging bladder. Further
studies are necessary to evaluate fibrosis and its impact on
the bladder biomechanics and sensory signaling in the
bladder wall, as well as mechanisms underlying fibrosis and
possible venues for treatment.
4. The immune system
The influence of immune system in aging bladder is far less
understood; however, it is conceivable that age decreases in
the ability of the immune system to react to insults (e.g.,
urinary tract infections). Recent studies have found changes
in genes involved in the immune response, including prote-
ase granzyme (Gzm) (Gzma,Gzmb,Gzmc) [55]. These results
suggest that voiding dysfunctions are associated with im-
mune and inflammatory related responses in the bladder and
afferent system (DRG).
5. Conclusion
There are a number of limitations associated with animal
models, both in terms of the particular importance of the
non-adrenergic non-cholinergic innervation seen in rodents
and the limitations of the model systems as proxies for the
human condition. Allowing for these clear limitations there
is however no doubt that such data gives us insight into
potential avenues for further research and the potential
development of new therapies. Clearly both myogenic and
neurogenic changes are found in rodent aging bladder. The
structural and functional changes observed in animal
models are somewhat similar to those observed in humans.
Clearly there is significant variability in the data obtained
from different species, strains of animal, their gender and
the methodology utilized. Based on our review we believe
the translational importance of future work will be
increased if both in vivo and in vitro parameters could be
studied in the same animal species.
References
[1] Birder L, Andersson KE. Urothelial signaling. Physiol Rev 2013;
93:653e80.
[2] Birder LA. Urothelial signaling. Auton Neurosci 2010;153:
33e40.
[3] Chai TC, Andersson KE, Tuttle JB, Steers WD. Altered neural
control of micturition in the aged F344 rat. Urol Res 2000;28:
348e54.er insights from animal models, Asian Journal of Urology (2017),
The bladder insights from animal models 5
+ MODEL[4] Chang SL, Howard PS, Koo HP, Macarak EJ. Role of type III
collagen in bladder filling. Neurourol Urodyn 1998;17:135e45.
[5] Chua WC, Howard PS, Koo HP, Macarak EJ. Age-related
changes of P2X(1) receptor mRNA in the bladder detrusor from
men with and without bladder outlet obstruction. Exp Ger-
ontol 2007;42:686e92.
[6] Chun AL, Wallace LJ, Gerald MC, Levin RM, Wein AJ. Effect of
age on in vivo urinary bladder function in the rat. J Urol 1988;
139:625e7.
[7] Chun AL, Wallace LJ, Gerald MC, Wein AJ, Levin RM. Effects of
age on urinary bladder function in the male rat. J Urol 1989;
141:170e3.
[8] Daly DM, Nocchi L, Liaskos M, McKay NG, Chapple C, Grundy D.
Age-related changes in afferent pathways and urothelial
function in the male mouse bladder. J Physiol 2014;592(Pt 3):
537e49.
[9] de Barros CA, Lorenzetti F, Ortiz V, Dambros M. Testosterone
supplementation’s effects on age-related bladder remodeling
e experimental study in rats. Aging Male 2013;16:102e7.
[10] de Groat WC. Integrative control of the lower urinary tract:
preclinical perspective. Br J Pharmacol 2006;147(Suppl. 2):
S25e40.
[11] DuBeau CE, Morrow JD, Kraus SR, Creanga D, Bavendam T.
Efficacy and tolerability of fesoterodine versus tolterodine in
older and younger subjects with overactive bladder: a post
hoc, pooled analysis from two placebo-controlled trials.
Neurourol Urodyn 2012;31:1258e65.
[12] Dubeau CE, Kraus SR, Griebling TL, Newman DK, Wyman JF,
Johnson TM, et al. Effect of fesoterodine in vulnerable elderly
subjects with urgency incontinence: a double-blind, placebo
controlled trial. J Urol 2014;191:395e404.
[13] Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric
voiding dysfunction. II. Aging detrusor: normal versus
impaired contractility. J Urol 1993;150(5 Pt 2):1657e67.
[14] Elbadawi A, Resnick NM, Dörsam J, Yalla SV, Haferkamp A.
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